Malcisbo Ltd.
Verified IntelSweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.
Sweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 1-10
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Corporate address undisclosed
- City
- Zurich
- Region / State
- Zurich
- Postal Code
- 8053
- Country
- Switzerland
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for Malcisbo Ltd..